MELD-based liver allocation: Who is underserved?

Seminars in Liver Disease

Volumn 26, Issue 3, 2006, Pages 211-220

  Biggins, Scott W ^a   Bambha, Kiran ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Allocation; Exceptions; Liver transplantation; MELD; Public policy

Indexed keywords

ACCURACY; BILIRUBIN BLOOD LEVEL; CALCULATION; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DYING; GRAFT RECIPIENT; HEALTH CARE DISTRIBUTION; HEALTH CARE POLICY; HUMAN; LIVER FAILURE; LIVER GRAFT; MATHEMATICAL ANALYSIS; MODEL; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; ORGAN DONOR; PARAMETER; PATIENT SELECTION; PORTAL HYPERTENSION; PREDICTION; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

HUMANS; HYPERTENSION, PORTAL; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; PATIENT SELECTION; RESIDENCE CHARACTERISTICS; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS;

EID: 33746561309     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947291     Document Type: Review

References (45)

1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871
2. Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneau T, Kosberg C. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470
3. Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000;6:543-552
4. Institute of Medicine. Analysis of waiting times. In: Committee on Organ Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC: National Academy Press; 1999:57
5. Organ Procurement and Transplantation Network-HRSA. Final rule with comment period. Fed Regist 1998;63:16296-16338
6. Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984;4:430-435
7. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96
8. UNOS. Organ Distribution: Allocation of Livers Policy 3.6. Available at: www.unos.org. Accessed March 4, 2006
9. Kremers WK, Van IM, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004;39:764-769
10. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15
11. 2004 OPTN/SRTR Annual Report. HHC/HRSA/HSB/DOT; UNOS; URREA.
12. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313
13. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003;9:12-18
14. Bambha K, Kim WR, Kremers WK, et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004;4:1798-1804
15. Report of the OPTN/UNOS Liver and Intestinal Organ Transplantation Committee to the Board of Directors, June 26-27, 2003
16. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 2004;291:1871-1874
17. Washburn K, Harper A, Klintmalm G, Goss J, Halff G. Regional sharing for adult status 1 candidates: reduction in waitlist mortality. Liver Transpl 2006;12:470-474
18. Humar A, Khwaja K, Glessing B, et al. Regionwide sharing for status 1 liver patients: beneficial impact on waiting time and pre- and posttransplant survival. Liver Transpl 2004;10:661-665
19. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005;241:905-916
20. 2005 OPTN/SRTR Annual Report. HHC/HRSA/HSB/DOT; UNOS; URREA.
21. Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 2005;5:2244-2247
22. UNOS Liver and Intestine Committee. Proposal for Standard Guidelines for MELD/PELD Exceptions. Available at: www.unos.org. Accessed January 3, 2006
23. Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-858
24. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001;7:567-580
25. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810
26. Heuman DM, Mihas A. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Gastroenterology 2003;125:992-993; author reply 994-995
27. Ripoll C, Banares R, Rincon D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. Hepatology 2005;42:793-801
28. Schrier RW, Gurevich AK, Cadnapaphornchai MA. Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis. Semin Nephrol 2001;21:157-172
29. Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162:323-328
30. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46-52
31. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005;41:32-39
32. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11:336-343
33. Biggins S, Kim W, Terrault N, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:1652-1660
34. Adler M, Verset D, Bouhdid H, et al. Prognostic evaluation of patients with parenchymal cirrhosis: proposal of a new simple score. J Hepatol 1997;26:642-649
35. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903
36. Bajaj JS, Saeian K. MELD score does not discriminate against patients with hepatic encephalopathy. Dig Dis Sci 2005;50:753-756
37. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599-612
38. Chalasani N, Kahi C, Francois F, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002;35:1282-1284
39. Brandsaeter B, Broome U, Isoniemi H, et al. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl 2003;9:961-969
40. Heimbach JK, Haddock MG, Alberts SR, et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl 2004;10:S6S-S68
41. Stock PG. Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD. Liver Transpl 2005;11:1315-1317
42. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003;75:425-429
43. Ragni MV, Belle SH, Im K, et al. Liver transplantation in HIV-seropositive individuals. Ann Intern Med 2006;144: 223author reply 223-224
44. Kayali Z, Ranguelov R, Mitros F, et al. Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis. Liver Int 2005;25:41-48
45. Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005;5:2605-2610